AUDREY OWEIMRIN: Open Payments
NPI 1053173427 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 82 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,250 · 2025 $1,619
Food & beverage: $1,619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $376 |
| AstraZeneca Pharmaceuticals LP | 12 | $267 |
| GlaxoSmithKline, LLC. | 9 | $190 |
| Kowa Pharmaceuticals America, Inc. | 10 | $142 |
| Exact Sciences Corporation | 4 | $112 |
| PFIZER INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $67 |
| Amgen Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $52 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
Products named: QULIPTA, AIRSUPRA, ZORYVE, TRELEGY ELLIPTA, UBRELVY, Cologuard Collection Kit, VRAYLAR, BEVESPI AEROSPHERE.
Industry payments across CT — which companies pay providers there.
